Berman Tabacco is liaison counsel for the class in this securities fraud class action brought under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and SEC Rule 10b-5 on behalf of all persons or entities that purchased or otherwise acquired Bayer Aktiengesellschaft’s (“Bayer”) publicly traded American Depositary Receipts from May 23, 2016 and July 6, 2020, inclusive, and were damaged as a result. The case relates to Bayer’s $63 billion acquisition of The Monsanto Company in 2018. Plaintiffs allege that Bayer, a multi-national pharmaceutical and life sciences corporation, and certain of its current and former executives made false and misleading statements to investors about the extent of their pre-merger due diligence related to Monsanto, a provider of agricultural and other chemicals, and the litigation risks relating to its top-selling Roundup herbicide product. As further alleged, following the merger, Bayer faced numerous defeats in court related to a large toxic-tort dispute involving Roundup and was ultimately forced to establish a more than $10.9 billion settlement fund to address current and future Roundup claims.
On May 19, 2023, the Honorable Richard Seeborg of the United States District Court for the Northern District of California granted class certification in full.